Uncategorized Guest User 9/4/12 Uncategorized Guest User 9/4/12 Sequestration Potentially to INCLUDE Industry User Fees Read More Analysis and Commentary Guest User 8/24/12 Analysis and Commentary Guest User 8/24/12 Bringing IT at the FDA into the 21st Century Read More Advocacy at a Glance Guest User 8/24/12 Advocacy at a Glance Guest User 8/24/12 Update on FY 13 Continuing Resolution and Congressional Deficit Negotiations and more Read More Uncategorized Guest User 8/24/12 Uncategorized Guest User 8/24/12 Erratum Read More Analysis and Commentary Guest User 8/20/12 Analysis and Commentary Guest User 8/20/12 Relative -- as Opposed to Absolute -- Levels of FDA Funding Read More Analysis and Commentary Guest User 8/13/12 Analysis and Commentary Guest User 8/13/12 Honest assessment of priorities: a Congressional imperative for FDA Read More Advocacy at a Glance Guest User 8/13/12 Advocacy at a Glance Guest User 8/13/12 President Obama signs Sequestration Transparency Act and more Read More Advocacy at a Glance Guest User 8/8/12 Advocacy at a Glance Guest User 8/8/12 Betting on a 6-Month-Long, CR-based Compromise Read More Advocacy at a Glance Guest User 8/8/12 Advocacy at a Glance Guest User 8/8/12 Office of Management and Budget Guidance to Government Agencies Regarding Potential Sequestration and more Read More Analysis and Commentary Guest User 7/27/12 Analysis and Commentary Guest User 7/27/12 Potentially Increased Risk for Cutbacks as the Squeeze Tightens Read More Advocacy at a Glance Guest User 7/27/12 Advocacy at a Glance Guest User 7/27/12 Update on FY 13 Continuing Resolution and more Read More Analysis and Commentary Guest User 7/20/12 Analysis and Commentary Guest User 7/20/12 Through the Crystal Ball Darkly Read More Advocacy at a Glance Guest User 7/20/12 Advocacy at a Glance Guest User 7/20/12 FDA Chief Information Officer Meeting, August 22 and more Read More Analysis and Commentary Guest User 7/15/12 Analysis and Commentary Guest User 7/15/12 Sustaining FDA Remains a National Priority Read More Advocacy at a Glance Guest User 7/15/12 Advocacy at a Glance Guest User 7/15/12 Office of Management and Budget Meeting and more Read More Analysis and Commentary Guest User 6/28/12 Analysis and Commentary Guest User 6/28/12 A Delay Until July ... And What May Happen Read More Analysis and Commentary Guest User 6/28/12 Analysis and Commentary Guest User 6/28/12 It's Not a "Normal" Year ... And So ... Read More Analysis and Commentary Guest User 6/22/12 Analysis and Commentary Guest User 6/22/12 What If There's a Sequester? Read More Analysis and Commentary Guest User 6/10/12 Analysis and Commentary Guest User 6/10/12 The FDA's Best Case, Optimistic Scenario for FY 13 Read More Advocacy at a Glance Guest User 6/10/12 Advocacy at a Glance Guest User 6/10/12 FDA Receives 2.481 Billion in House Appropriations Agriculture Subcommittee Mark-Up and more Read More Newer Posts Older Posts
Uncategorized Guest User 9/4/12 Uncategorized Guest User 9/4/12 Sequestration Potentially to INCLUDE Industry User Fees Read More
Analysis and Commentary Guest User 8/24/12 Analysis and Commentary Guest User 8/24/12 Bringing IT at the FDA into the 21st Century Read More
Advocacy at a Glance Guest User 8/24/12 Advocacy at a Glance Guest User 8/24/12 Update on FY 13 Continuing Resolution and Congressional Deficit Negotiations and more Read More
Analysis and Commentary Guest User 8/20/12 Analysis and Commentary Guest User 8/20/12 Relative -- as Opposed to Absolute -- Levels of FDA Funding Read More
Analysis and Commentary Guest User 8/13/12 Analysis and Commentary Guest User 8/13/12 Honest assessment of priorities: a Congressional imperative for FDA Read More
Advocacy at a Glance Guest User 8/13/12 Advocacy at a Glance Guest User 8/13/12 President Obama signs Sequestration Transparency Act and more Read More
Advocacy at a Glance Guest User 8/8/12 Advocacy at a Glance Guest User 8/8/12 Betting on a 6-Month-Long, CR-based Compromise Read More
Advocacy at a Glance Guest User 8/8/12 Advocacy at a Glance Guest User 8/8/12 Office of Management and Budget Guidance to Government Agencies Regarding Potential Sequestration and more Read More
Analysis and Commentary Guest User 7/27/12 Analysis and Commentary Guest User 7/27/12 Potentially Increased Risk for Cutbacks as the Squeeze Tightens Read More
Advocacy at a Glance Guest User 7/27/12 Advocacy at a Glance Guest User 7/27/12 Update on FY 13 Continuing Resolution and more Read More
Analysis and Commentary Guest User 7/20/12 Analysis and Commentary Guest User 7/20/12 Through the Crystal Ball Darkly Read More
Advocacy at a Glance Guest User 7/20/12 Advocacy at a Glance Guest User 7/20/12 FDA Chief Information Officer Meeting, August 22 and more Read More
Analysis and Commentary Guest User 7/15/12 Analysis and Commentary Guest User 7/15/12 Sustaining FDA Remains a National Priority Read More
Advocacy at a Glance Guest User 7/15/12 Advocacy at a Glance Guest User 7/15/12 Office of Management and Budget Meeting and more Read More
Analysis and Commentary Guest User 6/28/12 Analysis and Commentary Guest User 6/28/12 A Delay Until July ... And What May Happen Read More
Analysis and Commentary Guest User 6/28/12 Analysis and Commentary Guest User 6/28/12 It's Not a "Normal" Year ... And So ... Read More
Analysis and Commentary Guest User 6/22/12 Analysis and Commentary Guest User 6/22/12 What If There's a Sequester? Read More
Analysis and Commentary Guest User 6/10/12 Analysis and Commentary Guest User 6/10/12 The FDA's Best Case, Optimistic Scenario for FY 13 Read More
Advocacy at a Glance Guest User 6/10/12 Advocacy at a Glance Guest User 6/10/12 FDA Receives 2.481 Billion in House Appropriations Agriculture Subcommittee Mark-Up and more Read More
